Postprandial hyperglycaemia: Potential relationship to the development and progression of diabetic nephropathy

Diabetes, Obesity and Metabolism

Volumn 2, Issue SUPPL. 1, 2000, Pages

  Feldt Rasmussen, Bo ^a,b  

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Glycaemic control; Nephropathy; Pathophysiology; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; KIDNEY SIZE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PROTEINURIA; REVIEW; RISK FACTOR; RISK MANAGEMENT;

EID: 0034522948     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2000.00016.x     Document Type: Review

References (64)

1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
2. UKPDS and beyond: Into the next millennium
3. Preventing end-stage renal disease
4. Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark
5. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study
6. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus
7. Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: Pathophysiological mechanisms and intervention studies
8. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes
9. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study
10. The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type I diabetes mellitus
11. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors
12. Prevention of diabetic renal disease with special reference to microalbuminuria
13. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
14. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study
15. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients
16. Prospective study of microalbuminuria as predictor of mortality in NIDDM
17. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM
18. Albuminuria and poor glycemic control predict mortality in NIDDM
19. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
20. Eight to nine year mortality in known non-insulin dependent diabetics and controls
21. Albumin excretion and vascular deaths in NIDDM
22. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study 'Diabetes Care in General Practice', Denmark
23. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes
24. Diabetic control and microvascular complications: The near-normoglycaemic experience
25. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes
26. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: An update of the Steno studies
27. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
28. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
29. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria
30. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients
31. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
32. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
33. Prandial glucose regulation and cardiovascular disease in Type 2 disease
34. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
35. Hemodynamic factors in the genesis of diabetic microangiopathy
36. Diabetic nephropathy. A perspective
37. Albuminuria reflects widespread vascular damage. The Steno hypothesis
38. Maximum tubular reabsorption capacity for glucose and renal hemodynamics during rapid hypertonic glucose infusion in normal and diabetic subjects
39. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics
40. Insulin lispro limits post-prandial hyperglycaemia and hyperfiltration in type-2 diabetes
41. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus
42. Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment
43. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus
44. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients
45. Kidney function and size in diabetics before and during initial insulin treatment
46. Increased kidney size and glomerular filtration rate in early juvenile diabetes
47. Kidney size in diabetes mellitus
48. Relationship of renal size to nephropathy in type 1 (insulin-dependent) diabetes
49. Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: Effect of long-term improved metabolic control
50. Kidney function and cardiovascular risk factors in non-insulin-dependent diabetics (NIDDM) with microalbuminuria
51. Measurements of changes in kidney volume in experimental diabetes and pregnancy by NMR
52. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
53. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38
54. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study
55. Urinary albumin excretion: An independent predictor of ischemic heart disease
56. Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: A unifying concept
57. Cyclic guanosine monophosphate as a mediator of vasodilation
58. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
59. Features of endothelial dysfunction in early diabetic nephropathy
60. Postprandial glucose and vascular disease
61. Acute hyperglycaemia and oxidative stress generation
62. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria
63. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects
64. The postprandial state and risk of cardiovascular disease